Role of γδ T cells in α-galactosylceramide-mediated immunity

Journal of Immunology

Volumn 188, Issue 8, 2012, Pages 3928-3939

  Paget, Christophe ^a   Chow, Melvyn T ^a,b   Duret, Helene ^a   Mattarollo, Stephen R ^a,c   Smyth, Mark J ^a,b  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; CD1D ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 12P35; INTERLEUKIN 13; INTERLEUKIN 18; INTERLEUKIN 4; INTERLEUKIN 5; OVALBUMIN;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE; BYSTANDER EFFECT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL MEDIATED CYTOTOXICITY; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; GAMMA DELTA T LYMPHOCYTE; GENE TARGETING; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOMODULATION; INNATE IMMUNITY; LUNG METASTASIS; MOUSE; NATURAL KILLER CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TREATMENT OUTCOME; TUMOR CELL; TUMOR IMMUNITY; WILD TYPE;

ADAPTIVE IMMUNITY; ANIMALS; ANTIGENS, CD1D; CARCINOMA, LEWIS LUNG; CYTOTOXICITY, IMMUNOLOGIC; GALACTOSYLCERAMIDES; IMMUNITY, INNATE; INTERLEUKIN-12; INTERLEUKIN-18; KILLER CELLS, NATURAL; LIVER; LUNG NEOPLASMS; LYMPHOCYTE ACTIVATION; LYMPHOMA, B-CELL; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PROTEIN BINDING; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; SPLEEN; T-LYMPHOCYTES;

EID: 84860340264     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1103582     Document Type: Article

References (54)

1. Morita, M., K. Motoki, K. Akimoto, T. Natori, T. Sakai, E. Sawa, K. Yamaji, Y. Koezuka, E. Kobayashi, and H. Fukushima. 1995. Structure-activity relationship of α-galactosylceramides against B16-bearing mice. J. Med. Chem. 38: 2176-2187.
2. Kawano, T., J. Cui, Y. Koezuka, I. Toura, Y. Kaneko, K. Motoki, H. Ueno, R. Nakagawa, H. Sato, E. Kondo, et al. 1997. CD1d-restricted and TCR-mediated activation of vα14 NKT cells by glycosylceramides. Science 278: 1626-1629. (Pubitemid 27516282)
3. Bendelac, A., P. B. Savage, and L. Teyton. 2007. The biology of NKT cells. Annu. Rev. Immunol. 25: 297-336. (Pubitemid 46697911)
4. Cerundolo, V., J. D. Silk, S. H. Masri, and M. Salio. 2009. Harnessing invariant NKT cells in vaccination strategies. Nat. Rev. Immunol. 9: 28-38.
5. Godfrey, D. I., and M. Kronenberg. 2004. Going both ways: immune regulation via CD1d-dependent NKT cells. J. Clin. Invest. 114: 1379-1388. (Pubitemid 40385565)
6. Chung, Y., W. S. Chang, S. Kim, and C. Y. Kang. 2004. NKT cell ligand α-galactosylceramide blocks the induction of oral tolerance by triggering dendritic cell maturation. Eur. J. Immunol. 34: 2471-2479. (Pubitemid 39302804)
7. Fujii, S., K. Shimizu, C. Smith, L. Bonifaz, and R. M. Steinman. 2003. Activation of natural killer T cells by α-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein. J. Exp. Med. 198: 267-279. (Pubitemid 36987852)
8. Carnaud, C., D. Lee, O. Donnars, S. H. Park, A. Beavis, Y. Koezuka, and A. Bendelac. 1999. Cutting edge: cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells. J. Immunol. 163: 4647-4650. (Pubitemid 29501223)
9. Nieuwenhuis, E. E., T. Matsumoto, M. Exley, R. A. Schleipman, J. Glickman, D. T. Bailey, N. Corazza, S. P. Colgan, A. B. Onderdonk, and R. S. Blumberg. 2002. CD1d-dependent macrophage-mediated clearance of Pseudomonas aeruginosa from lung. Nat. Med. 8: 588-593. (Pubitemid 34633436)
10. Singh, N., S. Hong, D. C. Scherer, I. Serizawa, N. Burdin, M. Kronenberg, Y. Koezuka, and L. Van Kaer. 1999. Cutting edge: activation of NK T cells by CD1d and α-galactosylceramide directs conventional T cells to the acquisition of a Th2 phenotype. J. Immunol. 163: 2373-2377. (Pubitemid 29399153)
11. + T cells in vivo. J. Immunol. 170: 2540-2548. (Pubitemid 36245644)
12. Galli, G., P. Pittoni, E. Tonti, C. Malzone, Y. Uematsu, M. Tortoli, D. Maione, G. Volpini, O. Finco, S. Nuti, et al. 2007. Invariant NKT cells sustain specific B cell responses and memory. Proc. Natl. Acad. Sci. USA 104: 3984-3989. (Pubitemid 47181565)
13. + natural killer T cells mature dendritic cells, leading to strong adaptive immunity. Immunol. Rev. 220: 183-198. (Pubitemid 350045564)
14. Van Kaer, L., and S. Joyce. 2005. Innate immunity: NKT cells in the spotlight. Curr. Biol. 15: R429-R431. (Pubitemid 40772144)
15. Hayakawa, Y., K. Takeda, H. Yagita, S. Kakuta, Y. Iwakura, L. Van Kaer, I. Saiki, and K. Okumura. 2001. Critical contribution of IFN-γa and NK cells, but not perforin-mediated cytotoxicity, to anti-metastatic effect of α-galactosylceramide. Eur. J. Immunol. 31: 1720-1727. (Pubitemid 32547334)
16. Nishimura, T., H. Kitamura, K. Iwakabe, T. Yahata, A. Ohta, M. Sato, K. Takeda, K. Okumura, L. Van Kaer, T. Kawano, et al. 2000. The interface between innate and acquired immunity: glycolipid antigen presentation by CD1d-expressing dendritic cells to NKT cells induces the differentiation of antigen-specific cytotoxic T lymphocytes. Int. Immunol. 12: 987-994. (Pubitemid 30601366)
17. + T cells and natural killer cells is essential for the antimetastatic effect of α-galactosylceramide. Blood 99: 1259-1266. (Pubitemid 34547079)
18. Takeda, K., Y. Hayakawa, M. Atsuta, S. Hong, L. Van Kaer, K. Kobayashi, M. Ito, H. Yagita, and K. Okumura. 2000. Relative contribution of NK and NKT cells to the anti-metastatic activities of IL-12. Int. Immunol. 12: 909-914. (Pubitemid 30410463)
19. Bonneville, M., R. L. O'Brien, and W. K. Born. 2010. γδ T cell effector functions: a blend of innate programming and acquired plasticity. Nat. Rev. Immunol. 10: 467-478.
20. Born, W. K., Z. Yin, Y. S. Hahn, D. Sun, and R. L. O'Brien. 2010. Analysis of gamma delta T cell functions in the mouse. J. Immunol. 184: 4055-4061.
21. Hayday, A. C. 2009. γδ T cells and the lymphoid stress-surveillance response. Immunity 31: 184-196.
22. Gardner, T. R., Q. Chen, Y. Jin, and M. N. Ajuebor. 2010. Toll-like receptor 3 ligand dampens liver inflammation by stimulating Vα14 invariant natural killer T cells to negatively regulate γδ T cells. Am. J. Pathol. 176: 1779-1789.
23. Zhao, N., J. Hao, Y. Ni, W. Luo, R. Liang, G. Cao, Y. Zhao, P. Wang, L. Zhao, Z. Tian, et al. 2011. Vγ4 γδ T cell-derived IL-17A negatively regulates NKT cell function in Con A-induced fulminant hepatitis. J. Immunol. 187: 5007-5014.
24. Jin, N., N. Miyahara, C. L. Roark, J. D. French, M. K. Aydintug, J. L. Matsuda, L. Gapin, R. L. O'Brien, E. W. Gelfand, and W. K. Born. 2007. Airway hyperresponsiveness through synergy of gammadelta T cells and NKT cells. J. Immunol. 179: 2961-2968.
25. Cheng, L., Y. Cui, H. Shao, G. Han, L. Zhu, Y. Huang, R. L. O'Brien, W. K. Born, H. J. Kaplan, and D. Sun. 2008. Mouse γδ T cells are capable of expressing MHC class II molecules, and of functioning as antigen-presenting cells. J. Neuroimmunol. 203: 3-11.
26. Lalor, S. J., L. S. Dungan, C. E. Sutton, S. A. Basdeo, J. M. Fletcher, and K. H. Mills. 2011. Caspase-1-processed cytokines IL-1β and IL-18 promote IL-17 production by γδ and CD4 T cells that mediate autoimmunity. J. Immunol. 186: 5738-5748.
27. Martin, B., K. Hirota, D. J. Cua, B. Stockinger, and M. Veldhoen. 2009. Interleukin-17-producing γδ T cells selectively expand in response to pathogen products and environmental signals. Immunity 31: 321-330.
28. Sutton, C. E., S. J. Lalor, C. M. Sweeney, C. F. Brereton, E. C. Lavelle, and K. H. Mills. 2009. Interleukin-1 and IL-23 induce innate IL-17 production from γδ T cells, amplifying Th17 responses and autoimmunity. Immunity 31: 331-341.
29. + cells into the liver. Eur. J. Immunol. 40: 1328-1341.
30. Cui, J., T. Shin, T. Kawano, H. Sato, E. Kondo, I. Toura, Y. Kaneko, H. Koseki, M. Kanno, and M. Taniguchi. 1997. Requirement for Vα14 NKT cells in IL-12-mediated rejection of tumors. Science 278: 1623-1626. (Pubitemid 27516281)
31. Takeda, K., H. Tsutsui, T. Yoshimoto, O. Adachi, N. Yoshida, T. Kishimoto, H. Okamura, K. Nakanishi, and S. Akira. 1998. Defective NK cell activity and Th1 response in IL-18-deficient mice. Immunity 8: 383-390. (Pubitemid 28188898)
32. Paget, C., T. Mallevaey, A. O. Speak, D. Torres, J. Fontaine, K. C. Sheehan, M. Capron, B. Ryffel, C. Faveeuw, M. Leite de Moraes, et al. 2007. Activation of invariant NKT cells by Toll-like receptor 9-stimulated dendritic cells requires type I interferon and charged glycosphingolipids. Immunity 27: 597-609. (Pubitemid 47628833)
33. Smyth, M. J., M. Taniguchi, and S. E. Street. 2000. The anti-tumor activity of IL-12: mechanisms of innate immunity that are model and dose dependent. J. Immunol. 165: 2665-2670. (Pubitemid 30660715)
34. Smyth, M. J., N. Y. Crowe, and D. I. Godfrey. 2001. NK cells and NKT cells collaborate in host protection from methylcholanthrene-induced fibrosarcoma. Int. Immunol. 13: 459-463. (Pubitemid 32288543)
35. O'Brien, R. L., and W. K. Born. 2010. γδ T cell subsets: a link between TCR and function? Semin. Immunol. 22: 193-198.
36. Ribot, J. C., A. deBarros, D. J. Pang, J. F. Neves, V. Peperzak, S. J. Roberts, M. Girardi, J. Borst, A. C. Hayday, D. J. Pennington, and B. Silva-Santos. 2009. CD27 is a thymic determinant of the balance between interferon-γ- and interleukin 17-producing γδ T cell subsets. Nat. Immunol. 10: 427-436.
37. Kitamura, H., K. Iwakabe, T. Yahata, S. Nishimura, A. Ohta, Y. Ohmi, M. Sato, K. Takeda, K. Okumura, L. Van Kaer, et al. 1999. The natural killer T (NKT) cell ligand α-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells. J. Exp. Med. 189: 1121-1128.
38. Das, H., M. Sugita, and M. B. Brenner. 2004. Mechanisms of Vδ1 γδ T cell activation by microbial components. J. Immunol. 172: 6578-6586. (Pubitemid 38669092)
39. Smyth, M. J., M. E. Wallace, S. L. Nutt, H. Yagita, D. I. Godfrey, and Y. Hayakawa. 2005. Sequential activation of NKT cells and NK cells provides effective innate immunotherapy of cancer. J. Exp. Med. 201: 1973-1985. (Pubitemid 41002933)
40. Adams, J. M., A. W. Harris, C. A. Pinkert, L. M. Corcoran, W. S. Alexander, S. Cory, R. D. Palmiter, and R. L. Brinster. 1985. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature 318: 533-538. (Pubitemid 16173038)
41. Fujii, S., K. Liu, C. Smith, A. J. Bonito, and R. M. Steinman. 2004. The linkage of innate to adaptive immunity via maturing dendritic cells in vivo requires CD40 ligation in addition to antigen presentation and CD80/86 costimulation. J. Exp. Med. 199: 1607-1618. (Pubitemid 38821994)
42. + T cell responses to soluble antigen in vivo through direct interaction with dendritic cells. J. Immunol. 171: 5140-5147. (Pubitemid 37432797)
43. Tessmer, M. S., A. Fatima, C. Paget, F. Trottein, and L. Brossay. 2009. NKT cell immune responses to viral infection. Expert Opin. Ther. Targets 13: 153-162.
44. Tupin, E., Y. Kinjo, and M. Kronenberg. 2007. The unique role of natural killer T cells in the response to microorganisms. Nat. Rev. Microbiol. 5: 405-417. (Pubitemid 46780078)
45. Wu, L., and L. Van Kaer. 2009. Natural killer T cells and autoimmune disease. Curr. Mol. Med. 9: 4-14.
46. Cooper, M. A., T. A. Fehniger, A. Fuchs, M. Colonna, and M. A. Caligiuri. 2004. NK cell and DC interactions. Trends Immunol. 25: 47-52. (Pubitemid 38032807)
47. Lauwerys, B. R., N. Garot, J. C. Renauld, and F. A. Houssiau. 2000. Cytokine production and killer activity of NK/T-NK cells derived with IL-2, IL-15, or the combination of IL-12 and IL-18. J. Immunol. 165: 1847-1853. (Pubitemid 30643135)
48. Ribot, J. C., A. debarros, and B. Silva-Santos. 2011. Searching for "signal 2": costimulation requirements of γδ T cells. Cell. Mol. Life Sci. 68: 2345-2355.
49. Wesch, D., C. Peters, H. H. Oberg, K. Pietschmann, and D. Kabelitz. 2011. Modulation of γδ T cell responses by TLR ligands. Cell. Mol. Life Sci. 68: 2357-2370.
50. Curtis, M. M., and S. S. Way. 2009. Interleukin-17 in host defence against bacterial, mycobacterial and fungal pathogens. Immunology 126: 177-185.
51. Iwakura, Y., S. Nakae, S. Saijo, and H. Ishigame. 2008. The roles of IL-17A in inflammatory immune responses and host defense against pathogens. Immunol. Rev. 226: 57-79.
52. Wondimu, Z., T. Santodomingo-Garzon, T. Le, and M. G. Swain. 2010. Protective role of interleukin-17 in murine NKT cell-driven acute experimental hepatitis. Am. J. Pathol. 177: 2334-2346.
53. Zhou, F. 2009. Molecular mechanisms of IFN-gamma to up-regulate MHC class I antigen processing and presentation. Int. Rev. Immunol. 28: 239-260.
54. Brandes, M., K. Willimann, and B. Moser. 2005. Professional antigen-presentation function by human gammadelta T Cells. Science 309: 264-268. (Pubitemid 40967855)